GILEAD SCIENCES, INC. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
GILEAD SCIENCES, INC. (GILD) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $37.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-08-06
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-06-30 was $1.00M, a 93.33% decline year-over-year.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-03-31 was $36.00M.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $23.00M.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $17.00M.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $55.00M, a 83.18% decline from fiscal 2024.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $327.00M, a 75.49% decline from fiscal 2023.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $1.33B, a 16.10% decline from fiscal 2022.
- GILEAD SCIENCES, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $1.59B, a 27.06% decline from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month as first filed | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month as first filed | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month as first filed | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $37.00M 10-Q · filed 2026-08-06 | $60.00M derived: sum of 3 quarters · filed 2026-08-06 | $77.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $36.00M 10-Q · filed 2026-05-07 | $59.00M derived: sum of 2 quarters · filed 2026-05-07 | $76.00M derived: sum of 3 quarters · filed 2026-05-07 | $91.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $40.00M derived: sum of 2 quarters · filed 2026-02-24 | $55.00M derived: sum of 3 quarters · filed 2026-08-06 | $55.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $32.00M derived: sum of 2 quarters · filed 2026-08-06 | $32.00M 10-Q · filed 2025-11-07 | $32.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.00M 10-Q · filed 2026-08-06 | $15.00M derived: sum of 3 quarters · filed 2026-08-06 | $15.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $327.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $327.00M 10-Q · filed 2025-11-07 | $676.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $327.00M 10-Q · filed 2025-08-07 | $676.00M derived: sum of 3 quarters · filed 2026-02-24 | $942.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $327.00M 10-Q · filed 2025-05-07 | $676.00M derived: sum of 2 quarters · filed 2026-02-24 | $942.00M derived: sum of 3 quarters · filed 2026-02-24 | $1.34B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $349.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $615.00M derived: sum of 2 quarters · filed 2026-02-24 | $1.01B derived: sum of 3 quarters · filed 2026-02-24 | $1.33B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $266.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $661.00M derived: sum of 2 quarters · filed 2024-11-12 | $985.00M 10-Q · filed 2024-11-12 | $1.34B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $395.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $719.00M 10-Q · filed 2024-08-08 | $1.08B derived: sum of 3 quarters · filed 2025-02-28 | $1.35B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $324.00M 10-Q · filed 2024-05-08 | $682.00M derived: sum of 2 quarters · filed 2025-02-28 | $959.00M derived: sum of 3 quarters · filed 2025-02-28 | $1.41B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $358.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $635.00M derived: sum of 2 quarters · filed 2025-02-28 | $1.08B derived: sum of 3 quarters · filed 2025-02-28 | $1.59B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $277.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $726.00M derived: sum of 2 quarters · filed 2023-11-07 | $1.23B 10-Q · filed 2023-11-07 | $1.60B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $449.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $955.00M 10-Q · filed 2023-08-04 | $1.33B derived: sum of 3 quarters · filed 2024-02-23 | $1.89B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $506.00M 10-Q · filed 2023-05-03 | $878.00M derived: sum of 2 quarters · filed 2024-02-23 | $1.44B derived: sum of 3 quarters · filed 2024-02-23 | $2.07B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $372.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $930.00M derived: sum of 2 quarters · filed 2024-02-23 | $1.56B derived: sum of 3 quarters · filed 2024-02-23 | $2.18B 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $558.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.19B derived: sum of 2 quarters · filed 2022-11-02 | $1.81B 10-Q · filed 2022-11-02 | $2.76B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $631.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.25B 10-Q · filed 2022-08-08 | $2.20B derived: sum of 3 quarters · filed 2023-02-22 | $4.50B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $619.00M 10-Q · filed 2022-05-04 | $1.57B derived: sum of 2 quarters · filed 2023-02-22 | $3.87B derived: sum of 3 quarters · filed 2023-02-22 | $6.65B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $951.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.25B derived: sum of 2 quarters · filed 2023-02-22 | $6.03B derived: sum of 3 quarters · filed 2023-02-22 | $9.48B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $2.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $5.08B derived: sum of 2 quarters · filed 2021-11-03 | $8.53B 10-Q · filed 2021-11-03 | $13.29B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $2.78B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $6.23B 10-Q · filed 2021-08-05 | $10.99B derived: sum of 3 quarters · filed 2022-02-23 | $18.60B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $3.45B 10-Q · filed 2021-05-06 | $8.21B derived: sum of 2 quarters · filed 2022-02-23 | $15.82B derived: sum of 3 quarters · filed 2022-02-23 | $19.34B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $4.76B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $12.37B derived: sum of 2 quarters · filed 2022-02-23 | $15.89B derived: sum of 3 quarters · filed 2022-02-23 | $22.40B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $7.61B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $11.13B derived: sum of 2 quarters · filed 2020-11-04 | $17.64B 10-Q · filed 2020-11-04 | $24.95B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $3.52B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $10.03B 10-Q · filed 2020-08-06 | $17.34B derived: sum of 3 quarters · filed 2021-02-25 | $22.83B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $6.51B 10-Q · filed 2020-05-06 | $13.83B derived: sum of 2 quarters · filed 2021-02-25 | $19.31B derived: sum of 3 quarters · filed 2021-02-25 | $26.09B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $7.32B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $12.80B derived: sum of 2 quarters · filed 2021-02-25 | $19.57B derived: sum of 3 quarters · filed 2021-02-25 | $24.34B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $5.48B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $12.26B derived: sum of 2 quarters · filed 2019-11-05 | $17.02B 10-Q · filed 2019-11-05 | $20.68B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $6.78B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $11.54B 10-Q · filed 2019-08-06 | $15.20B derived: sum of 3 quarters · filed 2020-02-25 | $17.42B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $4.76B 10-Q · filed 2019-05-08 | $8.42B derived: sum of 2 quarters · filed 2020-02-25 | $10.64B derived: sum of 3 quarters · filed 2020-02-25 | $11.85B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $3.66B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $5.88B derived: sum of 2 quarters · filed 2020-02-25 | $7.09B derived: sum of 3 quarters · filed 2020-02-25 | $7.82B 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $2.22B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $3.43B derived: sum of 2 quarters · filed 2018-11-06 | $4.16B 10-Q · filed 2018-11-06 | $4.73B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $1.21B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.94B 10-Q · filed 2018-08-06 | $2.51B derived: sum of 3 quarters · filed 2019-02-26 | $2.86B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $734.00M 10-Q · filed 2018-05-09 | $1.30B derived: sum of 2 quarters · filed 2019-02-26 | $1.65B derived: sum of 3 quarters · filed 2019-02-26 | $1.99B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $569.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $916.00M derived: sum of 2 quarters · filed 2019-02-26 | $1.26B derived: sum of 3 quarters · filed 2019-02-26 | $1.70B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $347.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $688.00M derived: sum of 2 quarters · filed 2017-11-07 | $1.13B 10-Q · filed 2017-11-07 | $1.48B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $341.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $784.00M 10-Q · filed 2017-08-07 | $1.13B derived: sum of 3 quarters · filed 2018-02-27 | $1.35B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $443.00M 10-Q · filed 2017-05-10 | $791.00M derived: sum of 2 quarters · filed 2018-02-27 | $1.01B derived: sum of 3 quarters · filed 2018-02-27 | $1.12B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $348.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $571.00M derived: sum of 2 quarters · filed 2018-02-27 | $681.00M derived: sum of 3 quarters · filed 2018-02-27 | $719.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $223.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $333.00M derived: sum of 2 quarters · filed 2016-11-07 | $371.00M 10-Q · filed 2016-11-07 | $396.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $110.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $148.00M 10-Q · filed 2016-08-05 | $173.00M derived: sum of 3 quarters · filed 2017-02-27 | $182.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $38.00M 10-Q · filed 2016-05-06 | $63.00M derived: sum of 2 quarters · filed 2017-02-27 | $72.00M derived: sum of 3 quarters · filed 2017-02-27 | $76.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $34.00M derived: sum of 2 quarters · filed 2017-02-27 | $38.00M derived: sum of 3 quarters · filed 2017-02-27 | $52.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $13.00M derived: sum of 2 quarters · filed 2015-11-04 | $27.00M 10-Q · filed 2015-11-04 | $26.58M 10-Q · filed 2014-11-05 | $47.44M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $18.00M 10-Q · filed 2015-08-05 | $17.59M 10-Q · filed 2014-08-04 | $38.44M derived: sum of 3 quarters · filed 2016-02-24 | $56.43M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $14.00M 10-Q · filed 2015-05-08 | $13.67M 10-Q · filed 2014-05-07 | $34.44M derived: sum of 2 quarters · filed 2016-02-24 | $52.43M derived: sum of 3 quarters · filed 2016-02-24 | $85.14M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $20.44M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $38.43M derived: sum of 2 quarters · filed 2016-02-24 | $71.14M derived: sum of 3 quarters · filed 2016-02-24 | $78.00M 10-K · filed 2016-02-24 | $77.66M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $17.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $50.69M derived: sum of 2 quarters · filed 2014-11-05 | $57.56M 10-Q · filed 2014-11-05 | $76.58M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $32.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $39.57M 10-Q · filed 2014-08-04 | $58.60M derived: sum of 3 quarters · filed 2015-02-25 | $81.62M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $6.86M 10-Q · filed 2014-05-07 | $25.89M derived: sum of 2 quarters · filed 2015-02-25 | $48.91M derived: sum of 3 quarters · filed 2015-02-25 | $51.86M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $19.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $42.05M derived: sum of 2 quarters · filed 2015-02-25 | $45.00M derived: sum of 3 quarters · filed 2015-02-25 | $45.00M 10-K · filed 2015-02-25 | $44.81M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $23.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $25.98M derived: sum of 2 quarters · filed 2013-10-31 | $25.98M 10-Q · filed 2013-10-31 | $307.86M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $2.95M 10-Q · filed 2013-08-01 | $284.83M derived: sum of 3 quarters · filed 2014-02-25 | $442.38M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $281.88M derived: sum of 2 quarters · filed 2014-02-25 | $439.43M derived: sum of 3 quarters · filed 2014-02-25 | $619.21M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $281.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $439.43M derived: sum of 2 quarters · filed 2014-02-25 | $619.21M derived: sum of 3 quarters · filed 2014-02-25 | $788.39M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $157.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $337.32M derived: sum of 2 quarters · filed 2012-11-06 | $506.51M 10-Q · filed 2012-11-06 | $598.79M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $179.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $348.97M 10-Q · filed 2012-08-01 | $441.25M derived: sum of 3 quarters · filed 2013-02-27 | $726.49M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $169.19M 10-Q · filed 2012-05-04 | $261.47M derived: sum of 2 quarters · filed 2013-02-27 | $546.71M derived: sum of 3 quarters · filed 2013-02-27 | $681.37M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $92.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $377.52M derived: sum of 2 quarters · filed 2013-02-27 | $512.18M derived: sum of 3 quarters · filed 2013-02-27 | $683.93M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $285.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $419.89M derived: sum of 2 quarters · filed 2011-11-04 | $591.65M 10-Q · filed 2011-11-04 | $664.31M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $134.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $306.41M 10-Q · filed 2011-08-05 | $379.07M derived: sum of 3 quarters · filed 2012-02-23 | $502.72M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $171.75M 10-Q · filed 2011-05-09 | $244.41M derived: sum of 2 quarters · filed 2012-02-23 | $368.06M derived: sum of 3 quarters · filed 2012-02-23 | $479.57M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $72.66M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $196.31M derived: sum of 2 quarters · filed 2012-02-23 | $307.82M derived: sum of 3 quarters · filed 2012-02-23 | $435.51M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $123.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $235.16M derived: sum of 2 quarters · filed 2010-11-08 | $362.85M 10-Q · filed 2010-11-08 | $387.52M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $111.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $239.20M 10-Q · filed 2010-08-09 | $263.87M derived: sum of 3 quarters · filed 2011-02-28 | $380.59M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $127.69M 10-Q · filed 2010-05-10 | $152.36M derived: sum of 2 quarters · filed 2011-02-28 | $269.08M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | $24.67M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $141.39M derived: sum of 2 quarters · filed 2011-02-28 | $193.69M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $116.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $169.02M 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $52.30M 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $195.40M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |